Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ConfometRx

- PMLiVE

Amgen says romosozumab on track for 2016 filing

Reports ‘significant’ reduction of fractures in post-menopausal osteoporosis patients

- PMLiVE

UCB bags FDA approval for epilepsy drug Briviact

Wins US licence as the add-on treatment is launched in Germany and the UK

- PMLiVE

Pascale Richetta moves from AbbVie to UCB

She joins the biopharmaceutical company as executive vice president

- PMLiVE

UCB wins European approval for epilepsy drug Briviact

Plans first launches within weeks

UCB trials wearable sensor for Parkinson’s

Its medical device combines with a mobile app to measure motor symptom patterns

- PMLiVE

UCB appoints new managing director of Britain and Ireland

Steve Turley joins from Lundbeck

- PMLiVE

UCB staff high five for arthritis

Firm supports the World Arthritis Day social media campaign

- PMLiVE

AstraZeneca and PatientsLikeMe team up on real-world data

Two groups hoping to harness the power of the patient forum network

- PMLiVE

Dr. Reddy’s enters €118m product agreement with UCB in India

Portfolio acquisition will expand firm’s therapy footprint

- PMLiVE

UCB and MRC join forces on novel antibody discovery platform

Will provide UK scientists with access to up-to-date technologies

- PMLiVE

UCB: Patient centricity should move a business forward

Pharma may become obsolete if it does not include the patient voice, says Lode Dewulf

- PMLiVE

UCB plans epilepsy ‘hackathon’ to develop new digital tools

Aims to attract developers, designers and digital experts to Hack Epilepsy

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links